DK1877773T3 - NEW APPARATUS AND PROCEDURE FOR THE COATING OF CARRIER SUBSTRATES FOR ANALYTICAL DETECTION BY THE AFFINITY DETECTION PROCEDURE - Google Patents
NEW APPARATUS AND PROCEDURE FOR THE COATING OF CARRIER SUBSTRATES FOR ANALYTICAL DETECTION BY THE AFFINITY DETECTION PROCEDURE Download PDFInfo
- Publication number
- DK1877773T3 DK1877773T3 DK06724515.9T DK06724515T DK1877773T3 DK 1877773 T3 DK1877773 T3 DK 1877773T3 DK 06724515 T DK06724515 T DK 06724515T DK 1877773 T3 DK1877773 T3 DK 1877773T3
- Authority
- DK
- Denmark
- Prior art keywords
- substrates
- liquid
- coating
- atomized
- coated
- Prior art date
Links
- 239000000758 substrate Substances 0.000 title claims description 210
- 238000000576 coating method Methods 0.000 title claims description 110
- 239000011248 coating agent Substances 0.000 title claims description 64
- 238000000034 method Methods 0.000 title claims description 55
- 238000001514 detection method Methods 0.000 title claims description 49
- 239000007788 liquid Substances 0.000 claims description 96
- 238000005259 measurement Methods 0.000 claims description 92
- 238000002161 passivation Methods 0.000 claims description 26
- 238000000889 atomisation Methods 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 6
- 238000003860 storage Methods 0.000 claims description 5
- 238000009827 uniform distribution Methods 0.000 claims description 5
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 239000010410 layer Substances 0.000 description 105
- 239000000243 solution Substances 0.000 description 46
- 238000003556 assay Methods 0.000 description 39
- 239000007921 spray Substances 0.000 description 36
- 230000027455 binding Effects 0.000 description 32
- 230000003287 optical effect Effects 0.000 description 25
- 239000000523 sample Substances 0.000 description 25
- 150000001875 compounds Chemical class 0.000 description 24
- 238000002493 microarray Methods 0.000 description 24
- 239000012491 analyte Substances 0.000 description 23
- 238000007598 dipping method Methods 0.000 description 23
- 230000005284 excitation Effects 0.000 description 23
- 239000007789 gas Substances 0.000 description 22
- 238000005507 spraying Methods 0.000 description 21
- 239000012716 precipitator Substances 0.000 description 18
- 230000009870 specific binding Effects 0.000 description 18
- 238000003491 array Methods 0.000 description 17
- 235000018102 proteins Nutrition 0.000 description 17
- 102000004169 proteins and genes Human genes 0.000 description 17
- 239000013592 cell lysate Substances 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 16
- 238000002604 ultrasonography Methods 0.000 description 16
- 239000000463 material Substances 0.000 description 15
- 239000011521 glass Substances 0.000 description 14
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 13
- 229940098773 bovine serum albumin Drugs 0.000 description 13
- 239000010409 thin film Substances 0.000 description 13
- -1 alkyl phosphates Chemical class 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 10
- 238000004113 cell culture Methods 0.000 description 10
- 230000008878 coupling Effects 0.000 description 10
- 238000010168 coupling process Methods 0.000 description 10
- 238000005859 coupling reaction Methods 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 8
- 238000004020 luminiscence type Methods 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 6
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 6
- 239000004793 Polystyrene Substances 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 230000007935 neutral effect Effects 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 108091033319 polynucleotide Proteins 0.000 description 6
- 102000040430 polynucleotide Human genes 0.000 description 6
- 239000002157 polynucleotide Substances 0.000 description 6
- 229920002223 polystyrene Polymers 0.000 description 6
- 230000019491 signal transduction Effects 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 229960004679 doxorubicin Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000010408 film Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 239000004642 Polyimide Substances 0.000 description 4
- 229920001213 Polysorbate 20 Polymers 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 4
- 239000012131 assay buffer Substances 0.000 description 4
- 208000013715 atelosteogenesis type I Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 150000001925 cycloalkenes Chemical class 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000001917 fluorescence detection Methods 0.000 description 4
- 210000001822 immobilized cell Anatomy 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 4
- 239000004417 polycarbonate Substances 0.000 description 4
- 229920000515 polycarbonate Polymers 0.000 description 4
- 229920001721 polyimide Polymers 0.000 description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
- 239000010453 quartz Substances 0.000 description 4
- 150000004760 silicates Chemical class 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 4
- 229920006352 transparent thermoplastic Polymers 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 241000972773 Aulopiformes Species 0.000 description 3
- 102000011632 Caseins Human genes 0.000 description 3
- 108010076119 Caseins Proteins 0.000 description 3
- 241000252203 Clupea harengus Species 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 3
- 108091006905 Human Serum Albumin Proteins 0.000 description 3
- 102000008100 Human Serum Albumin Human genes 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000019514 herring Nutrition 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 229920001477 hydrophilic polymer Polymers 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 235000019515 salmon Nutrition 0.000 description 3
- 150000004756 silanes Chemical class 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229910052581 Si3N4 Inorganic materials 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 125000005600 alkyl phosphonate group Chemical group 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002118 epoxides Chemical class 0.000 description 2
- 238000002073 fluorescence micrograph Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 238000009688 liquid atomisation Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229920006112 polar polymer Polymers 0.000 description 2
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- PBCFLUZVCVVTBY-UHFFFAOYSA-N tantalum pentoxide Inorganic materials O=[Ta](=O)O[Ta](=O)=O PBCFLUZVCVVTBY-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 239000012114 Alexa Fluor 647 Substances 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 108091093078 Pyrimidine dimer Proteins 0.000 description 1
- 102000015098 Tumor Suppressor Protein p53 Human genes 0.000 description 1
- 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- TVACALAUIQMRDF-UHFFFAOYSA-N dodecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCOP(O)(O)=O TVACALAUIQMRDF-UHFFFAOYSA-N 0.000 description 1
- 238000005401 electroluminescence Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000813 microcontact printing Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical class CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000004222 uncontrolled growth Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B17/00—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups
- B05B17/04—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods
- B05B17/06—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations
- B05B17/0607—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers
- B05B17/0615—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers spray being produced at the free surface of the liquid or other fluent material in a container and subjected to the vibrations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
Landscapes
- Health & Medical Sciences (AREA)
- Clinical Laboratory Science (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Sampling And Sample Adjustment (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH7352005 | 2005-04-26 | ||
| PCT/EP2006/003726 WO2006114249A1 (de) | 2005-04-26 | 2006-04-22 | Neue apparatur und verfahren zur beschichtung von trägersubstraten für einen analytnachweis mittels affinitäts-nachweisverfahren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1877773T3 true DK1877773T3 (en) | 2015-01-19 |
Family
ID=36808724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06724515.9T DK1877773T3 (en) | 2005-04-26 | 2006-04-22 | NEW APPARATUS AND PROCEDURE FOR THE COATING OF CARRIER SUBSTRATES FOR ANALYTICAL DETECTION BY THE AFFINITY DETECTION PROCEDURE |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9050615B2 (enExample) |
| EP (1) | EP1877773B1 (enExample) |
| JP (1) | JP5002584B2 (enExample) |
| CN (1) | CN101208599B (enExample) |
| AU (1) | AU2006239534B2 (enExample) |
| CA (1) | CA2605750A1 (enExample) |
| DK (1) | DK1877773T3 (enExample) |
| ES (1) | ES2525324T3 (enExample) |
| WO (1) | WO2006114249A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2485564A (en) * | 2010-11-18 | 2012-05-23 | Rolls Royce Plc | Luminescent surface coating for inspection |
| EP2726852B1 (en) | 2011-06-30 | 2020-11-25 | Koninklijke Philips N.V. | Multiple examinations of a sample |
| JP6384491B2 (ja) | 2014-01-10 | 2018-09-05 | コニカミノルタ株式会社 | イムノアッセイ法およびイムノアッセイシステム |
| DE102014112625A1 (de) * | 2014-09-02 | 2016-03-03 | Schmid Energy Systems Gmbh | Großflächen-Ultraschallverdampfer |
| WO2016094306A1 (en) * | 2014-12-08 | 2016-06-16 | Bloomfield Louis A | Compositions and methods for bonding glues, adhesives, and coatings to surfaces |
| CH712376A1 (de) | 2016-04-19 | 2017-10-31 | Camag | Derivatisierungsgerät und -verfahren. |
| CN106198952A (zh) * | 2016-07-01 | 2016-12-07 | 清华大学 | 一种抑制核酸分子对传感界面非特异性吸附的封闭方法 |
| CN107807133A (zh) * | 2017-11-08 | 2018-03-16 | 苏州安路特汽车部件有限公司 | 一种雾化渗透探伤装置 |
| AU2020266136B2 (en) * | 2019-04-29 | 2026-04-02 | Nautilus Subsidiary, Inc. | Methods and systems for integrated on-chip single-molecule detection |
| DE112022001298T5 (de) * | 2021-05-19 | 2023-12-28 | Swimc Llc | Flüssigkeits- oder aerosolstrahl-beschichtungszusammensetzungen für metallverpackungen, beschichtete substrate, verpackung und verfahren |
| CN115147617B (zh) * | 2022-09-06 | 2022-11-22 | 聊城集众环保科技有限公司 | 基于计算机视觉的污水处理智能监控方法 |
| CN115837944A (zh) * | 2023-02-16 | 2023-03-24 | 太原理工大学 | 一种电厂烟气注入采空区防灾封存的气体监测装置 |
| WO2026115152A1 (en) * | 2024-11-29 | 2026-06-04 | Leti Pharma, S.L.U. | Lysate concentration |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3514847A (en) * | 1966-05-10 | 1970-06-02 | Gen Dynamics Corp | Process for making photoconductive matrices |
| AU1944283A (en) | 1982-08-27 | 1984-03-29 | Ekins Roger Philip | Measurement of analyte concentration |
| JPS5955367A (ja) * | 1982-09-21 | 1984-03-30 | Tdk Corp | 静電防止剤塗布装置 |
| JPS6146028A (ja) * | 1984-08-10 | 1986-03-06 | Fujitsu Ltd | レジスト塗布装置 |
| GB8803000D0 (en) * | 1988-02-10 | 1988-03-09 | Ekins Roger Philip | Determination of ambient concentrations of several analytes |
| US5807755A (en) * | 1987-08-06 | 1998-09-15 | Multilyte Limited | Determination of ambient concentrations of several analytes |
| JPH01115450A (ja) * | 1987-10-28 | 1989-05-08 | Seiko Epson Corp | 潤滑層の形成方法 |
| US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| JPH03296460A (ja) * | 1990-04-13 | 1991-12-27 | Fujitsu General Ltd | フラックス塗付装置 |
| FR2669246A1 (fr) * | 1990-11-16 | 1992-05-22 | Centre Nat Rech Scient | Procede sol-gel de depot de couches minces par pulverisation ultrasonore. |
| EP0524301B1 (en) * | 1991-02-11 | 2002-07-24 | Thermo Biostar, Inc. | Ellipsometric immunoassay system and method including a thin film detection device |
| JPH06134367A (ja) * | 1992-04-10 | 1994-05-17 | Murata Mfg Co Ltd | 電子部品の外装構造 |
| IT1271969B (it) * | 1993-03-04 | 1997-06-10 | Mario Bonzi | Dispositivo per la umidificazione ed ionizzazione dell'aria |
| GB9326450D0 (en) * | 1993-12-24 | 1994-02-23 | Multilyte Ltd | Binding assay |
| MXPA96005828A (es) | 1994-05-27 | 2005-07-15 | Novartis Ag Tambien Denominada | Proceso para detectar luminescencia excitada evanescentemente. |
| WO1996035940A1 (en) | 1995-05-12 | 1996-11-14 | Novartis Ag | Sensor platform and method for the parallel detection of a plurality of analytes using evanescently excited luminescence |
| WO1997002856A1 (en) * | 1995-07-10 | 1997-01-30 | A & D Company, Limited | Handy atomizer |
| KR0144065B1 (ko) * | 1995-08-30 | 1998-08-01 | 배순훈 | 히터식 초음파 가습기 |
| US6143063A (en) * | 1996-03-04 | 2000-11-07 | Symetrix Corporation | Misted precursor deposition apparatus and method with improved mist and mist flow |
| US6395558B1 (en) | 1996-08-29 | 2002-05-28 | Zeptosens Ag | Optical chemical/biochemical sensor |
| US6045864A (en) * | 1997-12-01 | 2000-04-04 | 3M Innovative Properties Company | Vapor coating method |
| US6406921B1 (en) * | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
| JP4647792B2 (ja) | 1999-04-28 | 2011-03-09 | イジュノシッヒ テクニッヒ ホッフシューラ チューリッヒ | 分析用デバイスおよびセンシングデバイスにおけるポリイオン性コーティング |
| WO2001015800A1 (en) * | 1999-08-27 | 2001-03-08 | Picogram, Inc. | Method and device for performing operations at charged microlocations |
| US6510263B1 (en) | 2000-01-27 | 2003-01-21 | Unaxis Balzers Aktiengesellschaft | Waveguide plate and process for its production and microtitre plate |
| US20020064482A1 (en) | 2000-02-02 | 2002-05-30 | Tisone Thomas C. | Method and apparatus for developing DNA microarrays |
| JP2003531372A (ja) | 2000-04-14 | 2003-10-21 | ツェプトゼンス アクチエンゲゼルシャフト | 励起フィールドを強化するための格子導波路構造及びその使用 |
| EP1281063A1 (de) | 2000-05-06 | 2003-02-05 | Zeptosens AG | Gitter-wellenleiter-struktur für multianalytbestimmungen und deren verwendung |
| WO2002021110A1 (de) | 2000-09-04 | 2002-03-14 | Zeptosens Ag | System und verfahren zur multianalytbestimmung |
| EP1373875A2 (de) | 2001-04-02 | 2004-01-02 | Zeptosens AG | Optische struktur zur multi-photonen-anregung und deren verwendung |
| AU2002357547A1 (en) * | 2001-12-13 | 2003-06-23 | Zeptosens Ag | Optically transparent substrate for a maldi measuring system and the use thereof |
| EP1561109A1 (de) | 2002-09-03 | 2005-08-10 | Zeptosens AG | Analytische plattform und nachweisverfahren mit den in einer probe nachzuweisenden analyten als immobilisierten spezifischen bindungspartnern |
| DE10320312A1 (de) * | 2003-05-06 | 2004-12-02 | Friz Biochem Gmbh | Substrat als Träger von Ligaten |
| JP4318978B2 (ja) * | 2003-07-29 | 2009-08-26 | 独立行政法人科学技術振興機構 | 高分子固定化基板の製造方法およびこの方法により得られる高分子固定化基板 |
-
2006
- 2006-04-22 EP EP06724515.9A patent/EP1877773B1/de not_active Expired - Lifetime
- 2006-04-22 DK DK06724515.9T patent/DK1877773T3/en active
- 2006-04-22 ES ES06724515.9T patent/ES2525324T3/es not_active Expired - Lifetime
- 2006-04-22 US US11/919,054 patent/US9050615B2/en not_active Expired - Fee Related
- 2006-04-22 JP JP2008508125A patent/JP5002584B2/ja not_active Expired - Fee Related
- 2006-04-22 AU AU2006239534A patent/AU2006239534B2/en not_active Ceased
- 2006-04-22 CA CA002605750A patent/CA2605750A1/en not_active Abandoned
- 2006-04-22 WO PCT/EP2006/003726 patent/WO2006114249A1/de not_active Ceased
- 2006-04-22 CN CN200680023014.9A patent/CN101208599B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP5002584B2 (ja) | 2012-08-15 |
| ES2525324T3 (es) | 2014-12-22 |
| AU2006239534A1 (en) | 2006-11-02 |
| WO2006114249A1 (de) | 2006-11-02 |
| AU2006239534B2 (en) | 2012-05-31 |
| EP1877773B1 (de) | 2014-10-15 |
| EP1877773A1 (de) | 2008-01-16 |
| JP2008539399A (ja) | 2008-11-13 |
| CN101208599B (zh) | 2014-12-10 |
| CN101208599A (zh) | 2008-06-25 |
| US9050615B2 (en) | 2015-06-09 |
| CA2605750A1 (en) | 2006-11-02 |
| US20090311773A1 (en) | 2009-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5127718B2 (ja) | 複雑な組成を有する生物学的起源のサンプル中の１種若しくはそれ以上の被検体の測定方法およびその使用 | |
| CN101715552B (zh) | 用于处理液滴中样品的仪器及其使用方法 | |
| US7396675B2 (en) | Kit and method for determining a plurality of analytes | |
| AU2006239534B2 (en) | Novel equipment and method for coating substrates for analyte detection by way of an affinity assay method | |
| US20110172109A1 (en) | Device for the manipulation of limited quantities of liquids | |
| JP2004510130A5 (enExample) | ||
| JP2005537487A (ja) | 試料中において任意には分画された後の試料中において、固定化特異的結合パートナーとして測定される分析対象物を用いる分析プラットフォーム及び検出法 | |
| CN1954213A (zh) | 用于产生细胞群体的蛋白表达谱的分析平台和方法 | |
| JP2005537486A (ja) | 分析対象物が試料中で固定化された特異的結合パートナーとして測定される分析プラットフォーム及び検出法 | |
| CH703278A1 (fr) | Appareil et plate-forme pour analyse multiplex. | |
| KR100994306B1 (ko) | 바이오 어세이용 기판, 바이오 어세이 방법, 바이오 어세이 장치 및 기판 기록 정보의 판독 장치 |